Skip to main content
SpringerLink
Log in

Evidence-Based Practices for Co-occurring Addiction and Mental Illness

  • Chapter
  • First Online:
Textbook of Community Psychiatry

  • 816 Accesses

Abstract

Addiction is a chronic relapsing and remitting disorder that severely impacts the course, treatment, and prognosis of mental and physical disorders and presents complex challenges for providers. Conversely, severe mental illness (SMI) also impacts the course and treatment of substance use disorders (SUD). As co-occurring SUD and SMI are the rule rather than the exception, development of a co-occurring disorder (COD) program is essential for community-based psychiatric care. Integrated treatment for COD is evidenced-based psychosocial and pharmacological treatment, in which providers knowledgeable about both conditions treat mental illness and addictive disorders concurrently in the same program. Components and phases of integrated treatment are discussed as well as pharmacotherapy for COD, addictions, and tobacco cessation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • (CSAT), C. f. S. A. T. (2009). Addressing Suicidal thoughts and Behaviors in Substance Abuse Treatment. (HHS Publication No. (SMA) 09-4381). Rockville, MD: SAMHSA.

    Google Scholar 

  • (Ed.), C. f. S. A. T. (2005). Substance abuse treatment for persons with co-occurring disorders. Rockville, MD: Substance Abuse and Mental Health Services Administration.

    Google Scholar 

  • Agabio R., L. L. (2018). Baclofen in the Treatment of Patients with Alcohol Use Disorder and Other Mental Health Disorders. Front. Psychiatry, 29(9), 464. doi: https://doi.org/10.3389/fpsyt.2018.00464/fpsyt.2018.00464

  • Agosti, V., & Levin, F. R. (2006). One-year follow-up study of suicide attempters treated for drug dependence. Am J Addict, 15(4), 293–296.

    Google Scholar 

  • Anton RF, L. P., Voronin K, Book S, Hoffman M, Prisciandaro J, Bristol E. (2020). Efficacy of gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms: A randomized clinical trial. JAMA Intern Med, 180(5), 728–736.

    Article  PubMed  Google Scholar 

  • Back SE, M. J., Korte KJ, et al. ( 2016). A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders. J Clin Psychiatry, 77, e1439.

    Article  PubMed  PubMed Central  Google Scholar 

  • Batki S.L., P. D. L., Lasher B., et al. . (2014). Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res, 38, 2169.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bowden, C. L. (1995). Predictors of response to divalproex and lithium J Clin Psychiatry, 56(Suppl 3), 25–30.

    PubMed  Google Scholar 

  • Boyer, E. W. (2012). Management of opioid analgesic overdose N Engl J Med, 367(2), 146–155.

    Article  PubMed  PubMed Central  Google Scholar 

  • Brady, K. T., Sonne, S.C., Anton, R., Ballenger, J.C. (1995). Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse. J Clin Psychiatry, 56(3), 118–121.

    PubMed  Google Scholar 

  • Brandt L, C. T., Comer SD, Levin FR. (2020). Pharmacotherapeutic strategies for treating cocaine use disorder-what do we have to offer?. Addiction. doi: https://doi.org/10.1111/add.15242

  • Brunette MF, D. R., Xie H, McHugo GJ, Green AI. (2006). Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. Schizophr Bull, 32(4), 637–643.

    Article  PubMed  PubMed Central  Google Scholar 

  • Carpenter KM, B. A., Vosburg SK, Nunes EV. (2004). The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patient: a controlled clinical trial. Drug Alcohol Depend, 74(2), 123–134.

    Article  PubMed  Google Scholar 

  • Chan B, F. M., Kondo K, Ayers C, Montgomery J, Paynter R, et al. (2019a). Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis. Addiction, 114(12), 2122–2136.

    Article  PubMed  Google Scholar 

  • Chan, B., Kondo, K., Freeman, M., Ayers, C., Montgomery, J., Kansagara, D. (2019b). Pharmacotherapy for Cocaine Use Disorder-a Systematic Review and Meta-analysis. J Gen Intern Med, 34(12), 2858–2873.

    Article  PubMed  PubMed Central  Google Scholar 

  • Charach A., Y. E., Climans T., Lillie E. (2011). Childhood attention-deficit/ hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry, 50, 9–21.

    Article  PubMed  Google Scholar 

  • Chick J, L. O., Landron F. (2003). Does acamprosate improve reduction of drinking as well as aiding abstinence? J Psychopharmacol, 17(4), 397–402.

    Article  PubMed  Google Scholar 

  • Coffin PO, S. G.-M., Hern J, Vittinghoff E, Walker JE, Matheson T, et al. (2020). Effects of mirtazapine for methamphetamine use disorder among cisgender men and transgender women who have sex with men: A placebo-controlled randomized clinical trial JAMA Psychiatry, 77(3), 246–255.

    Google Scholar 

  • Comtois, K. A., Russo, J. E., Roy-Byrne, P., & Ries, R. K. (2004). Clinicians’ assessments of bipolar disorder and substance abuse as predictors of suicidal behavior in acutely hospitalized psychiatric inpatients. Biol Psychiatry, 56(10), 757–763.

    Article  PubMed  Google Scholar 

  • Cottler, L. B., Compton, W. M., 3rd, Mager, D., Spitznagel, E. L., & Janca, A. (1992). Posttraumatic stress disorder among substance users from the general population. Am J Psychiatry, 149(5), 664–670.

    Article  PubMed  Google Scholar 

  • Cunill R, C. X., Tobias A, et al. (2015). Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence. J Psychopharmacol (Oxford), 29, 15–23.

    Article  Google Scholar 

  • Dackis CA, K. K., Lynch KG, Pettinati HM, O’Brien CP. (2005). A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology, 30, 205–211.

    Article  PubMed  Google Scholar 

  • De Crescenzo F., C. S., Adamo N., Janiri L. (2016). Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review. Evid Based Ment Health, 20(1), 4–11.

    Article  PubMed  Google Scholar 

  • De Leon J, S. M., Diaz FJ, Rendon DM, Velásquez DM. (2005). Variables associated with alcohol, drug, and daily smoking cessation in patients with severe mental illnesses. J Clin Psychiatry, 66(11), 1447–1455.

    Article  PubMed  Google Scholar 

  • Dennis, M. L., Chan, Y. F., & Funk, R. R. (2006). Development and validation of the GAIN Short Screener (GAIN-SS) for psychopathology and crime/violence among adolescents and adults. American Journal on Addictions, 15(supplement 1), 80–91.

    Article  PubMed  Google Scholar 

  • Drake, R. E., Osher, F. C., Noordsy, D. L., Hurlbut, S. C., Teague, G. B., & Beaudett, M. S. (1990). Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull, 16(1), 57–67.

    Article  PubMed  Google Scholar 

  • Driessen, M., Meier, S., Hill, A., Wetterling, T., Lange, W., & Junghanns, K. (2001). The course of anxiety, depression, and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol and Alcoholism, 36(3), 249–255.

    Article  PubMed  Google Scholar 

  • Elkashef A, K. R., Yu E, Iturriaga E, Li SH, Anderson A, et al. (2012). Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial. . Addiction, 107(7), 1297–1306.

    Article  PubMed  PubMed Central  Google Scholar 

  • Elkashef AM, R. R., Anderson AL, Li SH, Holmes T, Smith EV, et al. (2008). Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology, 33(5), 1162–1170.

    Article  PubMed  Google Scholar 

  • Evins AE, C. C., Culhane MA, Birnbaum A, Horowitz J, Hsieh E, et al. (2007). A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. J Clin Psychopharmacol, 27(4), 380–386.

    Article  PubMed  Google Scholar 

  • Garbutt JC, K. H., O’Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, et al. (2005). Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA, 293(13), 1617–1625.

    Article  PubMed  Google Scholar 

  • Gastfriend, D., Mee-Lee, D (2004). The ASAM Patient Placement Criteria. J Addic Dis, 22(S1), 1–8. doi: https://doi.org/10.1300/J069v22S01_01

    Article  Google Scholar 

  • Gimeno C, Dorado ML, Roncero C., Szerman N., Vega P., Balanzá- Martínez V. et al. (2017). Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment Front Psychiatry, 8(173).

    Google Scholar 

  • Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., … Kaplan, K. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry, 61(8), 807–816.

    Article  PubMed  Google Scholar 

  • Greenfield SF, W. R., Muenz LR, Vagge LM, Kelly JF, et al. (1998). The effect of depression on return to drinking: a prospective study. Arch Gen Psychiatry, 55(3), 259–265.

    Article  PubMed  Google Scholar 

  • Groenman AP, O. J., Rommelse NJ, Franke B, Greven CU, et al. (2013). Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder. Br J Psychiatry, 203(2), 112–119.

    Article  PubMed  Google Scholar 

  • Haight, B. R., Learned, S.M., Laffont, C.M., Fudala, P.J., Zhao, Y., et al. (2019). Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Lancet, 393(10173), 778–790.

    Article  PubMed  Google Scholar 

  • Hall SM, P. J. (2009). Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annu Rev Clin Psychol, 5, 409–431.

    Google Scholar 

  • Harris EC, & Barraclough, B. (1997). Suicide as an outcome for mental disorders. Br J Psychiatry, 170, 205–228.

    Article  PubMed  Google Scholar 

  • Hasin, D. S., & Grant, B. F. (2002). Major depression in 6050 former drinkers: association with past alcohol dependence. Arch Gen Psychiatry, 59(9), 794–800.

    Article  PubMed  Google Scholar 

  • Hassan AN, H. A., Samokhvalov AV, Le Foll B, George TP (2017). Management of mood and anxiety disorders in patients receiving opioid agonist therapy: review and meta-analysis. Am J Addict, 26(6), 551–563. doi: https://doi.org/10.1111/ajad.12581

  • Hillemacher T, F. H. (2019). Pharmacotherapeutic options for co-morbid depression and alcohol dependence. . Expert Opin Pharmacother, 20(5), 547–569. doi: https://doi.org/10.1080/14656566.2018.1561870

  • Humphreys, K. L., Eng, T., Lee, S.S. (2013). Stimulant medication and substance use outcomes: a meta-analysis. JAMA Psychiatry, 70(7), 740–749.

    Article  PubMed  PubMed Central  Google Scholar 

  • Jayaram-Lindstrom N, H. A., Beck O, Franck J. (2008). Naltrexone for the treatment of amphetamine dependence: a randomized placebo-controlled trial. Am J Psychiatry, 165, 1142–1148.

    Article  Google Scholar 

  • Johanson BA, R. N., Capece, JA, Wiegand F, et al. (2007). Topiramate for treating alcohol dependence: a randomized controlled trial JAMA, 298(14), 1641–1651.

    Article  Google Scholar 

  • Johnson, B. A., Ait-Daoud, N., Wang, X.Q., Penberthy, J.K., Javors, M.A., Seneviratne, C., Liu, L. (2013). Topiramate for the treatment of cocaine addiction: a randomized clinical trial. JAMA Psychiatry, 70(12), 1338–1346.

    Google Scholar 

  • Jonas DE, A. H., Feltner C, Bobashev G, Thomas K, Wines R, et al. . (2014). Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis JAMA, 311(18), 1889–1900.

    Article  PubMed  Google Scholar 

  • Jones RM, L. P., Grann M, LÃ¥ngström N, Fazel S. (2011). Alcohol use disorders in schizophrenia: a national cohort study of 12,653 patients. J Clin Psychiatry, 72(6), 775–779.

    Article  PubMed  Google Scholar 

  • Kemp DE, G. K., Ganocy SJ, Elhaj O, Bilali SR, Conroy C, et al. (2009). A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence. J Clin Psychiatry, 70(1), 113–121. doi: https://doi.org/10.4088/jcp.07m04022

    Article  PubMed  Google Scholar 

  • Kessler, R. C., Sonnega, A., Bromet, E., Hughes, M., & Nelson, C. B. (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry, 52(12), 1048–1060.

    Article  PubMed  Google Scholar 

  • Klaire, S., Zivanovic, R., Barbic, S.P., Sandhu, R., Mathew, N., Azar, P. (2019). Rapid micro-induction of buprenorphine/naloxone for opioid use disorder in an inpatient setting: A case series Am J Addict, 28(4), 262–265.

    Google Scholar 

  • Konstenius M, J.-L. N., Guterstam J, Beck O, Philips B, Franck J, et al. (2014). Methylphenidate for attention deficit hyper-activity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial. Addiction, 109(3), 440–449.

    Article  PubMed  Google Scholar 

  • Kosten TR, R. B., Kleber HD. (1986). A 2.5 year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Arch Gen Psychiatry, 43(8), 733–738.

    Article  PubMed  Google Scholar 

  • Kranzler HR, F. R., Morris P, Hartwell EE. (2019 ). A meta-analysis of the efficacy of gabapentin for treating alcohol use disorder Addiction, 114(9), 1547–1555. doi: https://doi.org/10.1111/add.14655

    Article  PubMed  PubMed Central  Google Scholar 

  • Kranzler, H. R., Van Kirk, J. . (2001). Efficacy of naltrexone and acamprosate for alcoholism treatment. Alcohol Clin Exp Res, 25(9), 1335–1341.

    Article  PubMed  Google Scholar 

  • Lee, J. D., Nunes, E.V., Novo, P., Bachrach, K., Bailey, G.L., Bhatt, S., et al. (2018a). Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial Lancet, 391(10118), 309–318.

    Article  PubMed  Google Scholar 

  • Lee NK, J. L., Harney A, Cameron J. (2018b). Pharmacotherapy for amphetamine dependence: A systematic review. Drug Alcohol Depend, 191, 309–337.

    Article  PubMed  Google Scholar 

  • Levin FR, M. J., Specker S, Mooney M, Mahony A, Brooks DL, et al. (2015). Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry, 72(2), 593–602.

    Article  PubMed  PubMed Central  Google Scholar 

  • Li, M. Y., Shen, Y.C. (2008). Manic episode with psychosis following a lower than recommended dosage regimen of disulfiram. Prog Neuropsychopharmacol Biol Psychiatry, 32(1), 311–312.

    Article  PubMed  Google Scholar 

  • Ling W, C. L., Hillhouse M, Ang A, Striebel J, Jenkins J, et al. (2014). Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder. Addiction, 109(9), 1489–1500.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ma, J., Bao, Y.P., Wang, R.J., Su, M.F., Liu, M.X., Li, J.Q., et al. (2019). Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis Mol Psychiatry, 24(12), 1868–1883.

    Article  PubMed  Google Scholar 

  • Mann, K. (2004). Pharmacotherapy of alcohol dependence: a review of the clinical data. CNS Drugs, 18(8), 485–504.

    Article  PubMed  Google Scholar 

  • Marlatt, G. A., & Gordon, J. R. (1985). Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York: Guilford Publications.

    Google Scholar 

  • Mattick RP, B. C., Kimber J, Davoli M. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev, 2014(2), CD002207.

    Google Scholar 

  • Mattick RP, B. C., Kimber J, Davoli M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev, 2009(3), CD002209.

    PubMed Central  Google Scholar 

  • McDowell D, N. E., Seracine AM, Rothenberg J, Vosburg SK, Ma GJ, et al. (2005). Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. Drug Alcohol Depend, 80(2), 209–221.

    Article  PubMed  Google Scholar 

  • McElhiney MC, R. J., Rabkin R, Nunes EV. (2009). Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: a piolet study. Am J Drug Alcohol Abuse, 35(1), 34–37.

    Article  PubMed  PubMed Central  Google Scholar 

  • McGrath PJ, N. E., Stewart JW, Goldman D, Agosti V, Ocepek-Welikson K, et al. (1996). Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial. Arch Gen Psychiatry, 53(3), 232–240.

    Article  PubMed  Google Scholar 

  • McKay JR, P. H., Morrison R, Feeley M, Mulvaney FD, Gallop R. (2002). Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomizing continuing care study. Psychol Addict Behav, 16(3), 225–235.

    Article  PubMed  Google Scholar 

  • Minkoff, K., Cline, CA. (2004). Changing the world: the design and implementation of comprehensive continuous integrated systems of care for individuals with co-occurring disorders Psychatr Clin N Am, 27, 727–743.

    Google Scholar 

  • Modesto-Lowe V, K. H. (1999). Diagnosis and treatment of alcohol-dependent patients with co-morbid substance use disorders. Alcohol Res Health, 23(2), 144–149.

    Google Scholar 

  • Mueser, K. T., Bellack, A. S., & Blanchard, J. J. (1992). Comorbidity of schizophrenia and substance abuse: implications for treatment. J Consult Clin Psychol, 60(6), 845–856.

    Article  PubMed  Google Scholar 

  • Murphy, G. E., & Wetzel, R. D. (1990). The lifetime risk of suicide in alcoholism. Arch Gen Psychiatry, 47, 383–392.

    Article  PubMed  Google Scholar 

  • Musser KT, N. D., Drake RE, Flox L. (2003). Integrated Treatment for Dual Disorders. A Guide to Effective Practice. New York: Guilford Press.

    Google Scholar 

  • Myrick H, M. R., Randall PK, Boyle E, Anton RF, Becker HC, Randall CL. (2009). A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res, 33(9), 1582–1588.

    Article  PubMed  PubMed Central  Google Scholar 

  • Najavits, L. M., Weiss, R. D., & Shaw, S. R. (1997). The link between substance abuse and posttraumatic stress disorder in women. A research review. Am J Addict., 6(4), 273–283.

    Google Scholar 

  • Nunes, E. V., Liu, X., Samet, S., Matseoane, K., & Hasin, D. (2006). Independent versus substance-induced major depressive disorder in substance-dependent patients: observational study of course during follow-up. Journal of Clinical Psychiatry, 67(10), 1561–1567.

    Article  PubMed  Google Scholar 

  • Pettinati HM, O. D., Kanmpman KM, Dundon WD, Xie H, Gallis TL, et al. (2010). A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatr, 167(6), 668–675.

    Article  PubMed  Google Scholar 

  • Purvis TL, M. S., Balvanz TM, Magallon HE, Pham RH. (2009). Safety and effectiveness of varenicline in a veteran population with a high prevalence of mental illness. Ann Pharmacother, 43, 862–867.

    Article  PubMed  Google Scholar 

  • Rawson, R. A., McCann, M. J., Flammino, F., Shoptaw, S., Miotto, K., Reiber, C., & Ling, W. (2005). A comparison of contingency management and cognitive-behavioral approaches for stimulant -dependent individuals. Addiction, 101, 267–274.

    Article  Google Scholar 

  • Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Jama, 264(19), 2511–2518.

    Article  PubMed  Google Scholar 

  • Ries, R. K., Galanter, M., & Tonnigan, J. S. (2008). Twelve Step Facilitation: an adaptation for psychiatric practitioners and patients. In M. Galanter & H. Kleber (Eds.), Textbook of Substance Abuse Treatment (4th ed.). Arlington: American Psychiatric Publishing, Inc.

    Google Scholar 

  • Ries, R. K., Yuodelis-Flores, C., Roy-Byrne, P., Nilsson, O., & Russo, J. E. (2009). Addiction and Suicidal Behavior in Acute Psychiatric Inpatients. J. Compr Psychiatry, 50(2), 93–99.

    Article  Google Scholar 

  • Saitz, R. (2017). Should Benzodiazepines Be Used to Treat Anxiety in People With Substance Use Disorders? Contentious Debate With Similar Conclusions. Journal of Addiction Medicine, 11(2), 83.

    Article  PubMed  Google Scholar 

  • Salloum, I. M., Brown, E.S. (2017). Management of comorbid bipolar disorder and substance use disorders. Am J Drug Alcohol Abuse, 43(4), 366–376. doi: https://doi.org/10.1080/00952990.2017.1292279

    Article  PubMed  Google Scholar 

  • Sher L, Stanley BH, et al. (2008). Depressed patients with co-occurring alcohol-use disorders: a unique patient population. J Clin Psychiatry, 69, 907–915.

    Article  PubMed  Google Scholar 

  • Stokes PRA, J. T., Amawi S, Quereshi M, et al. (2020). Pharmacological Treatment of Mood Disorders and Comorbid Addictions: A Systematic Review and Meta-Analysis. Can J Psychiatry, 65(11), 749–769. doi: https://doi.org/10.1177/0706743720915420

    Article  PubMed  PubMed Central  Google Scholar 

  • Strakowski, S. M., Keck, P. E., Jr., McElroy, S. L., West, S. A., Sax, K. W., Hawkins, J. M., … Bourne, M. L. (1998). Twelve-month outcome after a first hospitalization for affective psychosis. Arch Gen Psychiatry, 55(1), 49–55.

    Google Scholar 

  • Tardelli VS, B. A., Arcadepani FB, Gerra G, Levin FR, et al. (2020). Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis Psychopharmacology (Berl), 237(8), 2233–2255. doi: https://doi.org/10.1007/s00213-020-05563-3

    Article  Google Scholar 

  • Terasaki, D., Smith, C., Calcaterra, S.L. . (2019). Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol. Pharmacotherapy, 39(10), 1023–1029.

    Article  PubMed  Google Scholar 

  • Tohen, M., Zarate, C. A., Jr., Hennen, J., Khalsa, H. M., Strakowski, S. M., Gebre-Medhin, P., … Baldessarini, R. J. (2003). The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry, 160(12), 2099–2107.

    Google Scholar 

  • Trivedi MH, W. R., Ling W, Dela Cruz A, Sharma G, et al. (2021 ). Bupropion and Naltrexone in Methamphetamine Use Disorder. N Engl J Med, 384(2), 140–153.

    Article  PubMed  PubMed Central  Google Scholar 

  • Weiss, R. D., Ostacher, M. J., Otto, M. W., Calabrese, J. R., Fossey, M., Wisniewski, S. R., … Sachs, G. S. (2005). Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry, 66(6), 730–735; quiz 808-739.

    Google Scholar 

  • Wilcox HC, Conner KR, & ED., C. ( 2004). Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies. Drug and Alcohol Dependence, 76(S), S11–S19.

    Article  PubMed  Google Scholar 

  • Yatham LN, K. S., Parikh SV, et al. (2018). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord, 20(2), 97–170. doi: https://doi.org/10.1111/bdi.12609

    Article  PubMed  PubMed Central  Google Scholar 

  • Ziedonis, D. M., Steinberg, M. L., D’Avanzo, K., & Smelson, D. (2004). Co--Occurring Schizophrenia and Addiction. In H. R. Kranzler & B. Rounsaville (Eds.), Dual Diagnosis and Psychiatric Treatment: Substance Abuse and Comorbid Disorders (2nd ed., pp. 387–436). New York: Marcel Drecker.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Behavioral Sciences, University of Washington, Harborview Addiction and Rehabilitation Programs, Harborview Medical Center, Seattle, WA, USA

    Christine Yuodelis-Flores

  2. Department of Psychiatry and Behavioral Sciences, University of Washington, Harborview Medical Center, Seattle, WA, USA

    Matthew Iles-Shih

  3. Division of Addictions, Department of Psychiatry and Behavioral Sciences, University of Washington, Harborview Medical Center, Seattle, WA, USA

    Richard K. Ries

Authors
  1. Christine Yuodelis-Flores
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthew Iles-Shih
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard K. Ries
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christine Yuodelis-Flores .

Editor information

Editors and Affiliations

  1. Clinical Professor of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

    Wesley E. Sowers

  2. Clinical Professor of Psychiatry, New York University Grossman School of Medicine | NYU Langone Health, New York, NY, USA

    Hunter L. McQuistion

  3. Clinical Professor of Psychiatry, Columbia University, Vagelos College of Physicians and Surgeons, New York, NY, USA

    Jules M. Ranz

  4. Professor Emerita of Psychiatry, Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA

    Jacqueline Maus Feldman

  5. Vice Chair/Professor, Department of Psychiatry, Case Western Reserve School of Medicine, Ohio, OH, USA

    Patrick S. Runnels

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yuodelis-Flores, C., Iles-Shih, M., Ries, R.K. (2022). Evidence-Based Practices for Co-occurring Addiction and Mental Illness. In: Sowers, W.E., McQuistion, H.L., Ranz, J.M., Feldman, J.M., Runnels, P.S. (eds) Textbook of Community Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-031-10239-4_25

Download citation

Publish with us

Policies and ethics

Search

Navigation